Anti-Diabetic Medication

Anti-Diabetic Medications work by either lowering down blood glucose level or by increasing sensitivity to insulin. Type 1 Diabetes is caused by lack of insulin hence, insulin has to be administered subcutaneously. Type 2 Diabetes is treated by oral hypoglycemic agents which act either by (a) increasing the amount of insulin secreted by the pancreas, (b) increasing the sensitivity of target organs to insulin or (c) decreasing the rate at which glucose is absorbed from the gastrointestinal tract.

  • Human Recombinant Insulin
  • Biguanides
  • Sulphonylureas
  • Meglitinides
  • Thiazolidinediones
  • Alpha-Glucosidase Inhibitors
  • Incretin Agonists

Related Conference of Anti-Diabetic Medication

February 27-28, 2019

Asia Pacific Diabetes and Endocrinology Congress

Tokyo, Japan

April 17-18, 2019

21st Asia Pacific Diabetes Conference

Osaka,Japan
May 17-18, 2019

2nd Global Experts Meeting on Diabetes, Hypertension & Metabolic Syndrome

Holiday Inn Singapore Atrium | Singapore
May 30-31, 2019

2nd Global Meeting on Diabetes and Endocrinology

Istanbul, Turkey
June 27-28, 2019 |

18th Global Conference on Diabetes & Nursing Care

Amsterdam, Netherlands
July 17-18, 2019

28th European Diabetes Congress

| Edinburgh, Scotland
July 24-25, 2019

29th World Diabetes & Heart Congress

Melbourne, Australia
July 29-30, 2019

12th International Conference on Diabetes & Metabolism

Chicago | Illinois| USA
September 19-20, 2019

15th World Congress on Endocrinology & Diabetes

| Prague, Czech Republic
Oct 03-04, 2019

Euro Diabetes Congress & Expo

| Paris, France
November 25-26, 2019

27th International Diabetes and Healthcare Conference

Istanbul, Turkey

Anti-Diabetic Medication Conference Speakers

Recommended Sessions

Related Journals

Are you interested in